More importantly, mast cells are able to intermediate leptin effects in even non-conventional mast cell-regulated physiological conditions, like for instance leptin-induced altered sympathetic activity (24), diarrhea-predominant irritable bowel syndrome (25) or coronary atherosclerosis (26). Here, LEP is linked to coronary atherosclerosis.